| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |